Limbo

Obstet Gynecol. 2018 Jun;131(6):959-960. doi: 10.1097/AOG.0000000000002610.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Chemical and Drug Induced Liver Injury
  • Drug Approval*
  • Female
  • Humans
  • Leiomyoma / drug therapy*
  • Norpregnadienes / adverse effects*
  • Norpregnadienes / pharmacology*
  • Periodicals as Topic
  • Pharmacovigilance
  • Progestins / antagonists & inhibitors
  • Randomized Controlled Trials as Topic
  • Uterine Neoplasms / drug therapy*

Substances

  • Norpregnadienes
  • Progestins
  • ulipristal